Skip to content

Dogwood Therapeutics DWTX Market capitalization

Market capitalization at other companies

Eli Lilly logo
Eli LillyLLY
$821.68B+10.8%
Pfizer logo
PfizerPFE
$159.73B+11.1%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$113.44B-8.9%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$1.05B+9.5%
Bioventus logo
BioventusBVS
$615.07M+1.6%
Avanos Medical logo
Avanos MedicalAVNS
$651.57M-1.2%

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0.0×
Current ratio5.9×-1.6×

Where this comes from

Computed from the period-end share price: $70.48M.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's market capitalization?
Dogwood Therapeutics (DWTX) reported market capitalization of $70.48M in Q1 2026.
How has Dogwood Therapeutics's market capitalization changed year-over-year?
Dogwood Therapeutics's market capitalization decreased by 43.2% year-over-year, from $124.12M to $70.48M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.